| Autor: |
Weijs TJ; Department of Surgery, University Medical Center Utrecht, Utrecht 3508GA, Netherlands., van Laarhoven HWM; Cancer Center Amsterdam, Cancer Treatment and Quality of Life, Amsterdam, Netherlands., Wijnhoven BPL; Department of Medical Oncology, Amsterdam UMC Location, University of Amsterdam, Amsterdam, Netherlands; Department of Surgery, Erasmus Medical Center Rotterdam, Rotterdam, Netherlands., Ruurda JP; Department of Surgery, University Medical Center Utrecht, Utrecht 3508GA, Netherlands., van Hillegersberg R; Department of Surgery, University Medical Center Utrecht, Utrecht 3508GA, Netherlands. Electronic address: r.vanhillegersberg@umcutrecht.nl. |
| Jazyk: |
angličtina |
| Zdroj: |
The lancet. Gastroenterology & hepatology [Lancet Gastroenterol Hepatol] 2024 Feb; Vol. 9 (2), pp. 103-104. |
| DOI: |
10.1016/S2468-1253(23)00407-7 |
| Abstrakt: |
Competing Interests: HWMvL declares research funding (to his institution) and receipt of equipment, materials, drugs, etc from Bayer, BMS, Celgene, Janssen, Incyte, Lilly, Merck, Nordic Pharma, Nordic, Philips, Roche, and Servier; and consulting fees (both to institution and personal) from BMS, Dragonfly, Lilly, Merck, Nordic Pharma, and Servier. BPLW has reveived research grants from BMS and was an unpaid member of the data safety monitoring board of Neo-AEGIS. JPR has received consulting fees from Intuitive Surgical. RvH has received consulting fees from Intuitive Surgical and Medtronic. TJW declares no competing interests. |
| Databáze: |
MEDLINE |
| Externí odkaz: |
|
